A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Yates, DR, Rehman, I, Meuth, M, Cross, S, Hamdy, F, Catto, J
Formáid:	Journal article
Foilsithe / Cruthaithe:	2006

Míreanna comhchosúla

Promoter hypermethylation identifies progression risk in bladder cancer.
de réir: Yates, DR, et al.
Foilsithe / Cruthaithe: (2007)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
de réir: Catto, J, et al.
Foilsithe / Cruthaithe: (2005)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
de réir: Yates, DR, et al.
Foilsithe / Cruthaithe: (2005)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
de réir: Catto, J, et al.
Foilsithe / Cruthaithe: (2007)

Genetic instability and transitional cell carcinoma of the bladder.
de réir: Catto, J, et al.
Foilsithe / Cruthaithe: (2004)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
de réir: Rouprêt, M, et al.
Foilsithe / Cruthaithe: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
de réir: Roupret, M, et al.
Foilsithe / Cruthaithe: (2008)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
de réir: Yates, DR, et al.
Foilsithe / Cruthaithe: (2006)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
de réir: Leiblich, A, et al.
Foilsithe / Cruthaithe: (2006)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer
de réir: Catto, J, et al.
Foilsithe / Cruthaithe: (2006)

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas
de réir: Ahmad, M, et al.
Foilsithe / Cruthaithe: (2003)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
de réir: Yates, D, et al.
Foilsithe / Cruthaithe: (2005)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
de réir: Roupret, M, et al.
Foilsithe / Cruthaithe: (2007)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
de réir: Dhawan, D, et al.
Foilsithe / Cruthaithe: (2006)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
de réir: Roupret, M, et al.
Foilsithe / Cruthaithe: (2007)

Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer.
de réir: Dudziec, E, et al.
Foilsithe / Cruthaithe: (2011)

In silico analysis of hypermethylation of E-cadherin gene promoter in Nasopharyngeal carcinoma
de réir: Lao Duc Thuan, et al.
Foilsithe / Cruthaithe: (2017-08-01)

The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
de réir: Changsong Zhang, Yang Ling, Chenghui Zhang, Yun Xu, Lu Gao, Rong Li, Jing Zhu, Lieying Fan, Lixin Wei
Foilsithe / Cruthaithe: (2012-01-01)

SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
de réir: Oztas Emin, et al.
Foilsithe / Cruthaithe: (2011-06-01)

Gene promoter hypermethylation in leukoplakia of the oral mucosa
de réir: Mingli Liu, et al.
Foilsithe / Cruthaithe: (2010-07-01)

In silico analysis of hypermethylation in CpGislands of UCHL1 gene’s promoter in nasopharyngeal carcinoma
de réir: Lao Duc Thuan, et al.
Foilsithe / Cruthaithe: (2018-08-01)

Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection.
de réir: Xiaoli Zhong, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Detection of CDH1 gene promoter hypermethylation in gastric cancer and chronic gastritis
de réir: Mitra Bayat, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Immune pressures drive the promoter hypermethylation of neoantigen genes
de réir: Ming Yi, et al.
Foilsithe / Cruthaithe: (2019-11-01)

Hypermethylation of MGMT and DAPK gene promoters is associated with tumorigenesis and metastasis in oral squamous cell carcinoma
de réir: Yong-Kie Wong, et al.
Foilsithe / Cruthaithe: (2011-09-01)

Promoter Hypermethylation Profile of Tumour Suppressor Genes in Oral Leukoplakia and Oral Squamous Cell Carcinoma
de réir: G. S. Asokan, et al.
Foilsithe / Cruthaithe: (2014-10-01)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
de réir: van Oers, J, et al.
Foilsithe / Cruthaithe: (2009)

NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription
de réir: Jian Zhang, et al.
Foilsithe / Cruthaithe: (2019-03-01)

Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain.
de réir: Patrick O McGowan, et al.
Foilsithe / Cruthaithe: (2008-05-01)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
de réir: Catto, J, et al.
Foilsithe / Cruthaithe: (2003)

LDLR gene’s promoter region hypermethylation in patients with familial hypercholesterolemia
de réir: R. A. Zorzo, et al.
Foilsithe / Cruthaithe: (2023-06-01)

DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334
de réir: Dapeng Sun, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Promoter hypermethylation-induced transcriptional down-regulation of the gene <it>MYCT1</it> in laryngeal squamous cell carcinoma
de réir: Yang Min, et al.
Foilsithe / Cruthaithe: (2012-06-01)

TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
de réir: Ma Ning, et al.
Foilsithe / Cruthaithe: (2010-11-01)

Putative tumour-suppressor gene <it>DAB2 </it>is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma
de réir: Chan Michael W, et al.
Foilsithe / Cruthaithe: (2010-06-01)

ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma
de réir: de Souza Emanuel M, et al.
Foilsithe / Cruthaithe: (2009-03-01)

Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients
de réir: Junhua Luo, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
de réir: Rehman, I, et al.
Foilsithe / Cruthaithe: (2004)

A comparative analysis of the behaviour of urothelial carcinoma with respect to anatomical location
de réir: Catto, J, et al.
Foilsithe / Cruthaithe: (2007)

Inactivation of the hypermethylated in cancer 1 tumour suppressor – not just a question of promoter hypermethylation?
de réir: M Jenal, et al.
Foilsithe / Cruthaithe: (2010-10-01)